Talcum Powder Cancer Lawsuit Leads To Qatar Ban

In reaction to the recent baby powder ovarian cancer lawsuit that awarded $72 million to the plaintiffs bringing charges against Johnson & Johnson, Qatar has temporarily banned the company's talcum powder products and ordered them pulled off shelves.

Wednesday, March 30, 2016 - A number of stores that sold baby powder products in Qatar have now pulled those products produced by Johnson & Johnson (J&J) after a talcum powder ovarian cancer lawsuit in St. Louis awarded the plaintiff $72 million in damages. The large penalty has sent shockwaves through the talcum powder industry, and these stores in Qatar are one of the first examples of stores actively pulling the product in response to the baby powder cancer lawsuit.

The assistant deputy of the department of specifications affairs Muhammad Seif Al-Kuwari announced last week that the news of a possible talcum powder ovarian cancer connection was sufficient to impose a temporary ban on the J&J baby powder products. Shortly after the talcum powder ovarian cancer lawsuit verdict was announced, Qatar announced that the country would put together a council to oversee the safety concerns related to the Johnson & Johnson baby powder products. It was likely from this council that the decision was made to temporarily pull the products from the shelves until further baby powder research could be conducted.

The talcum powder link to ovarian cancer has been speculated by scientists who have published studies on the subject since 1971. The St. Louis talcum powder cancer lawsuit was the first time a legal argument on behalf of those who believe the link is significant was granted damages by a jury. The final number of $72 million in damages, $62 million punitive and $10 compensatory, has caught the attention of news outlets and governments worldwide. Qatar may be out in front of the rest in taking the product off its shelves, but the worry is real for both distributors and consumers.

J&J has continued to claim that he talcum powder ovarian cancer lawsuits filed against the company have produced no significant evidence that counters studies it says proves that there is no significant link between baby powder products and cancer. However, this is the second time a jury has sided with a plaintiff after looking at the evidence both sides had to present and the legal momentum appears to be behind those filing talcum powder ovarian cancer lawsuits against J&J. Baby powder cancer attorneys have decades of research on their side, with new studies continuing to roll out in 2016.

The U.S. has not moved to ban J&J talcum powder products, and the FDA has yet to make an official declaration stating whether the agency has the evidence it needs to deem talc carcinogenic. The Indian government recently called for samples of J&J baby powder products to be tested by their Food and Drug Administration in response to the St. Louis talcum powder ovarian cancer lawsuits. While the Qatari government has claimed that the talcum powder ovarian cancer lawsuit will not necessarily lead to a permanent ban on the product in the country, the trust in the product has likely been irreparably damaged in the country. The government will continue to allow J&J products to be sold that do not contain talcum powder.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.